UNC Has Key Role in COVID-19 Drug Nearly Ready for Human Trials

Posted Apr 8, 2020
Scientists in Ralph Baric’s lab at UNC are playing a key role in the development and testing of a new drug, called EIDD-2801, that could change the way doctors treat COVID-19. The drug shows promise in reducing lung damage, has finished testing in mice and will soon move to human clinical trials. Baric is UNC’s Kenan Distinguished Professor of epidemiology. (Carolina Alumni Review)

Related: Campus Connections

UNC ranks as No. 1 best value public for 21st straight year
UNC-Chapel Hill delivers both excellence and affordability. Ranked No. 4 among public universities and No. 1 for best value among public institutions in the 2026...
Tue Sep 23, 2025

Former UNC Provost Dick Richardson remembered and honored for decades of service, mentorship
Richard “Dick” Richardson, a former UNC faculty member, department chair and provost, died peacefully at his home June 23 at the age of 90. He...
Mon Sep 22, 2025

UNC chemists create cleaner future for tires
Researchers at Carolina have introduced a novel chemical method for breaking down rubber waste. The journal Nature recently published the results of the U.S. Department...
Sun Sep 21, 2025

The history of neighboring towns Chapel Hill and Carrboro
Chapel Hill was founded with the purpose of serving the University. Originally organized by UNC's Board of Trustees, residents first arrived in 1795 — the...
Sat Sep 20, 2025